炎症性肠病相关脊柱关节炎患者的治疗:意大利炎症性肠病研究小组(IG-IBD)和意大利风湿病学会(SIR)根据伪德尔菲共识提出的建议。

IF 9.2 1区 医学 Q1 IMMUNOLOGY Autoimmunity reviews Pub Date : 2024-03-22 DOI:10.1016/j.autrev.2024.103533
Fabio Salvatore Macaluso , Flavio Caprioli , Laura Benedan , Cristina Bezzio , Roberto Caporali , Alberto Cauli , Maria Sole Chimenti , Francesco Ciccia , Salvatore D'Angelo , Massimo Claudio Fantini , Stefano Festa , Florenzo Iannone , Ennio Lubrano , Paolo Mariani , Claudio Papi , Giuseppe Provenzano , Daniela Pugliese , Antonio Rispo , Simone Saibeni , Carlo Salvarani , Roberto Gerli
{"title":"炎症性肠病相关脊柱关节炎患者的治疗:意大利炎症性肠病研究小组(IG-IBD)和意大利风湿病学会(SIR)根据伪德尔菲共识提出的建议。","authors":"Fabio Salvatore Macaluso ,&nbsp;Flavio Caprioli ,&nbsp;Laura Benedan ,&nbsp;Cristina Bezzio ,&nbsp;Roberto Caporali ,&nbsp;Alberto Cauli ,&nbsp;Maria Sole Chimenti ,&nbsp;Francesco Ciccia ,&nbsp;Salvatore D'Angelo ,&nbsp;Massimo Claudio Fantini ,&nbsp;Stefano Festa ,&nbsp;Florenzo Iannone ,&nbsp;Ennio Lubrano ,&nbsp;Paolo Mariani ,&nbsp;Claudio Papi ,&nbsp;Giuseppe Provenzano ,&nbsp;Daniela Pugliese ,&nbsp;Antonio Rispo ,&nbsp;Simone Saibeni ,&nbsp;Carlo Salvarani ,&nbsp;Roberto Gerli","doi":"10.1016/j.autrev.2024.103533","DOIUrl":null,"url":null,"abstract":"<div><p>Spondyloarthritis (SpA) is the most frequent extraintestinal manifestation in patients with inflammatory bowel diseases (IBD). When IBD and spondyloarthritis coexist, musculoskeletal and intestinal disease features should be considered when planning a therapeutic strategy. Treatment options for IBD and SpA have expanded enormously over the last few years, but randomized controlled trials with specific endpoints focused on SpA are not available in the IBD setting. To address this important clinical topic, the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and the Italian Society of Rheumatology (SIR) jointly planned to draw updated therapeutic recommendations for IBD-associated SpA using a pseudo-Delphi method. This document presents the official recommendations of IG-IBD and SIR on the management of IBD-associated SpA in the form of 34 statements and 4 therapeutic algorithms. It is intended to be a reference guide for gastroenterologists and rheumatologists dealing with IBD-associated SpA.</p></div>","PeriodicalId":8664,"journal":{"name":"Autoimmunity reviews","volume":"23 5","pages":"Article 103533"},"PeriodicalIF":9.2000,"publicationDate":"2024-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1568997224000247/pdfft?md5=95d2779faaa841c02b00711aa22154fa&pid=1-s2.0-S1568997224000247-main.pdf","citationCount":"0","resultStr":"{\"title\":\"The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus\",\"authors\":\"Fabio Salvatore Macaluso ,&nbsp;Flavio Caprioli ,&nbsp;Laura Benedan ,&nbsp;Cristina Bezzio ,&nbsp;Roberto Caporali ,&nbsp;Alberto Cauli ,&nbsp;Maria Sole Chimenti ,&nbsp;Francesco Ciccia ,&nbsp;Salvatore D'Angelo ,&nbsp;Massimo Claudio Fantini ,&nbsp;Stefano Festa ,&nbsp;Florenzo Iannone ,&nbsp;Ennio Lubrano ,&nbsp;Paolo Mariani ,&nbsp;Claudio Papi ,&nbsp;Giuseppe Provenzano ,&nbsp;Daniela Pugliese ,&nbsp;Antonio Rispo ,&nbsp;Simone Saibeni ,&nbsp;Carlo Salvarani ,&nbsp;Roberto Gerli\",\"doi\":\"10.1016/j.autrev.2024.103533\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Spondyloarthritis (SpA) is the most frequent extraintestinal manifestation in patients with inflammatory bowel diseases (IBD). When IBD and spondyloarthritis coexist, musculoskeletal and intestinal disease features should be considered when planning a therapeutic strategy. Treatment options for IBD and SpA have expanded enormously over the last few years, but randomized controlled trials with specific endpoints focused on SpA are not available in the IBD setting. To address this important clinical topic, the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and the Italian Society of Rheumatology (SIR) jointly planned to draw updated therapeutic recommendations for IBD-associated SpA using a pseudo-Delphi method. This document presents the official recommendations of IG-IBD and SIR on the management of IBD-associated SpA in the form of 34 statements and 4 therapeutic algorithms. It is intended to be a reference guide for gastroenterologists and rheumatologists dealing with IBD-associated SpA.</p></div>\",\"PeriodicalId\":8664,\"journal\":{\"name\":\"Autoimmunity reviews\",\"volume\":\"23 5\",\"pages\":\"Article 103533\"},\"PeriodicalIF\":9.2000,\"publicationDate\":\"2024-03-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S1568997224000247/pdfft?md5=95d2779faaa841c02b00711aa22154fa&pid=1-s2.0-S1568997224000247-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Autoimmunity reviews\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1568997224000247\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Autoimmunity reviews","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1568997224000247","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

脊柱关节炎(Spondyloarthritis,SPA)是炎症性肠病(IBD)患者最常见的肠外表现。当 IBD 和脊柱关节炎同时存在时,在制定治疗策略时应考虑肌肉骨骼和肠道疾病的特征。在过去几年中,IBD 和脊柱关节炎的治疗方案有了很大的扩展,但在 IBD 环境中,还没有针对脊柱关节炎的特定终点的随机对照试验。为了解决这一重要的临床课题,意大利炎症性肠病研究小组(IG-IBD)和意大利风湿病学会(SIR)共同计划采用伪德尔菲法,为 IBD 相关性 SpA 制定最新的治疗建议。本文件以 34 项声明和 4 种治疗算法的形式,介绍了 IG-IBD 和 SIR 对 IBD 相关性 SpA 治疗的官方建议。它旨在为消化内科医生和风湿病学家处理 IBD 相关性 SpA 提供参考指南。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus

Spondyloarthritis (SpA) is the most frequent extraintestinal manifestation in patients with inflammatory bowel diseases (IBD). When IBD and spondyloarthritis coexist, musculoskeletal and intestinal disease features should be considered when planning a therapeutic strategy. Treatment options for IBD and SpA have expanded enormously over the last few years, but randomized controlled trials with specific endpoints focused on SpA are not available in the IBD setting. To address this important clinical topic, the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and the Italian Society of Rheumatology (SIR) jointly planned to draw updated therapeutic recommendations for IBD-associated SpA using a pseudo-Delphi method. This document presents the official recommendations of IG-IBD and SIR on the management of IBD-associated SpA in the form of 34 statements and 4 therapeutic algorithms. It is intended to be a reference guide for gastroenterologists and rheumatologists dealing with IBD-associated SpA.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Autoimmunity reviews
Autoimmunity reviews 医学-免疫学
CiteScore
24.70
自引率
4.40%
发文量
164
审稿时长
21 days
期刊介绍: Autoimmunity Reviews is a publication that features up-to-date, structured reviews on various topics in the field of autoimmunity. These reviews are written by renowned experts and include demonstrative illustrations and tables. Each article will have a clear "take-home" message for readers. The selection of articles is primarily done by the Editors-in-Chief, based on recommendations from the international Editorial Board. The topics covered in the articles span all areas of autoimmunology, aiming to bridge the gap between basic and clinical sciences. In terms of content, the contributions in basic sciences delve into the pathophysiology and mechanisms of autoimmune disorders, as well as genomics and proteomics. On the other hand, clinical contributions focus on diseases related to autoimmunity, novel therapies, and clinical associations. Autoimmunity Reviews is internationally recognized, and its articles are indexed and abstracted in prestigious databases such as PubMed/Medline, Science Citation Index Expanded, Biosciences Information Services, and Chemical Abstracts.
期刊最新文献
Advancing understanding of autoimmune disease-related interstitial lung disease (AD-ILD): A global perspective on research focus and future directions. Is it time for treat to target in antiphospholipid syndrome? Global research landscape on antiphospholipid syndrome and systemic lupus erythematosus: Trends, collaborations, and future directions. Reply to "Refining search and keyword strategies in autoimmune ear disease bibliometric studies". Treatment of two pediatric patients with refractory systemic lupus erythematosus using CD19-targeted CAR T cells.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1